This article was originally published in The Gray Sheet
Senate Labor & Human Resources Committee will hold a hearing on nomination of FDA commissioner nominee Jane Henney on Sept. 1 if she is able to respond "in a timely manner" to a series of questions addressed to her July 31 by Chairman James Jeffords (R-Vt.), according to a same-day letter to Sens. Christopher Dodd (D-Conn.). Sens. Dodd, Barbara Mikulski (D-Md.), Paul Wellstone (D-Minn.) and Patty Murray (D-Wash.) signed a July 28 letter requesting the hearing. Henney met with Jeffords the week of July 20 to discuss the nomination
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.